ATE77547T1 - Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung. - Google Patents

Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.

Info

Publication number
ATE77547T1
ATE77547T1 AT88120153T AT88120153T ATE77547T1 AT E77547 T1 ATE77547 T1 AT E77547T1 AT 88120153 T AT88120153 T AT 88120153T AT 88120153 T AT88120153 T AT 88120153T AT E77547 T1 ATE77547 T1 AT E77547T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
preparation
extended action
active substance
microporous support
Prior art date
Application number
AT88120153T
Other languages
English (en)
Inventor
Mara Lucia Lovrecich
Original Assignee
Vectorpharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma Int filed Critical Vectorpharma Int
Application granted granted Critical
Publication of ATE77547T1 publication Critical patent/ATE77547T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT88120153T 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung. ATE77547T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
EP88120153A EP0336014B1 (de) 1988-04-08 1988-12-02 Pharmazeutische Zusammensetzungen mit verlängerter Wirkung und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE77547T1 true ATE77547T1 (de) 1992-07-15

Family

ID=11164167

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88120153T ATE77547T1 (de) 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.

Country Status (6)

Country Link
US (1) US5008114A (de)
EP (1) EP0336014B1 (de)
AT (1) ATE77547T1 (de)
DE (1) DE3872382T2 (de)
ES (1) ES2042700T3 (de)
IT (1) IT1216570B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290570A (en) * 1989-05-30 1994-03-01 Purepac, Inc. Lotions containing liquid-loaded powder
FR2694701B1 (fr) * 1990-04-18 1996-01-19 Biagianti Irene Application des zeolithes naturelles a l'homme et a l'environnement.
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
US5409903A (en) * 1992-02-18 1995-04-25 Urecap Corporation Method and compositions for the treatment of H. pylori and dermatitis
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
AU4932493A (en) * 1992-09-25 1994-04-26 Dynagen, Inc. An immunobooster for delayed release of immunogen
DK0669128T3 (da) * 1992-11-17 2000-06-19 Yoshitomi Pharmaceutical Sustained-release mikrosfære indeholdende antipsykotikum og fremgangsmåde til at fremstille samme
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
ES2236700T3 (es) * 1993-11-19 2005-07-16 Janssen Pharmaceutica N.V. 1,2-benzazoles microencapsulados.
DE4416001C2 (de) * 1994-05-06 1997-12-11 Feinchemie Gmbh Sebnitz Komposite zur steuerbaren Wirkstoff-Freisetzung
JP4484247B2 (ja) * 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
HU227939B1 (en) * 1996-05-29 2012-06-28 Delsitech Oy Dissolvable oxides for biological applications
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
PL204627B1 (pl) 1999-02-22 2010-01-29 Bayer Innovation Gmbh Sposób regulowania stopnia biologicznej degradacji przędzonego z zolu krzemionkowego włókna krzemionkowego, włókno krzemionkowe i jego zastosowanie
GB9904485D0 (en) * 1999-02-27 1999-04-21 Procter & Gamble Method for protecting and/or controlled release of active ingredient
EP1190123B1 (de) 1999-06-10 2002-10-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Einkapselung von kristallen mit mehrschichtigem überzug
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
EA006777B1 (ru) * 2001-06-22 2006-04-28 Пфайзер Продактс Инк. Фармацевтические композиции адсорбатов аморфного лекарственного средства
EP1269994A3 (de) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
EP1469832B2 (de) * 2002-02-01 2016-10-26 Bend Research, Inc. Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
CA2532931A1 (en) * 2003-08-04 2005-02-10 Pfizer Products Inc. Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
ITMI20071930A1 (it) * 2007-10-05 2009-04-06 Sasol Italy S P A Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso
EA031154B1 (ru) 2009-03-04 2018-11-30 Эмпликюре Аб Новый препарат, противодействующий злоупотреблению лекарством
MX2011011829A (es) 2009-05-08 2012-02-21 Orexo Ab Composicion para suministro sostenido de farmaco que comprende un aglutinante geopolimerico.
WO2012032337A2 (en) 2010-09-07 2012-03-15 Orexo Ab A transdermal drug administration device
US9526701B2 (en) * 2011-12-20 2016-12-27 Keith R. Latham Sustained drug release and improved product stability using non-covalent particle coating methods
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók
CN106456548A (zh) * 2014-03-31 2017-02-22 麻省理工学院 包括含药物活性物质化合物的多孔材料
GB201502073D0 (en) 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd HDEG technology

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923969A (en) * 1973-06-12 1975-12-02 Battelle Institut E V Carrier system for a drug with sustained release
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
GB8606468D0 (en) * 1986-03-15 1986-04-23 Sds Biotech Uk Ltd Therapeutic compositions
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
JPS6327502A (ja) * 1986-07-22 1988-02-05 Agency Of Ind Science & Technol シクロデキストリン−シリカ複合体及びその製造方法

Also Published As

Publication number Publication date
DE3872382D1 (de) 1992-07-30
IT1216570B (it) 1990-03-08
IT8820145A0 (it) 1988-04-08
DE3872382T2 (de) 1992-12-10
EP0336014A1 (de) 1989-10-11
US5008114A (en) 1991-04-16
EP0336014B1 (de) 1992-06-24
ES2042700T3 (es) 1993-12-16

Similar Documents

Publication Publication Date Title
ATE77547T1 (de) Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
EP0230647A3 (en) Method for producing a sustained release formulation
KR890007739A (ko) 안정화된 의약물질, 이의 제조방법, 및 안정한 의약제제
MA21182A1 (fr) Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant.
CA2009890A1 (en) Valproic acid
DE69012985D1 (de) Verkapselung von mischgetrockneter sucralose mit polyvinylacetat zur verwendung in kaugummi.
SE8305535D0 (sv) Lekemedelspreparat med antinikotinverkan och forfarande for framstellning derav
IL95691A0 (en) Thienylcarboxylates of amino alcohols,their preparation and pharmaceutical compositions containing them
DE68919010D1 (de) Purinverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
ATE38834T1 (de) 5-substituierte 1,2,4-oxadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0461630T3 (da) Fremgangsmåde til fremstilling af mikrokugler
IT1224405B (it) Composti attivi sul sistema cardiovascolare
AU7470287A (en) Pharmaceutical compositions with galactitol as carrier
ATE5188T1 (de) Phenylalkansaeure-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
ES2053535T3 (es) Derivados heterociclicos de cinco miembros de n,n'-diacilhidrazinas n' sustituidas.
DE68906572D1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ES2051731T3 (es) Un procedimiento para preparar antibioticos macrolidos y su uso.
DE3676491D1 (de) Gelatinekapseln mit gesteuerter wirkstofffreisetzung und verfahren zur herstellung derselben.
DE69016592D1 (de) 4-Amidino-Chroman und 4-Amidino-Pyrano(3,2-c)pyridinderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3881484D1 (de) Optisch aktive produkte von 20,21-dinoreburnamenin-derivaten, verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
KR870010872A (ko) 루프성 이뇨제의 경피 치료 시스템용 조성물의 제조방법
DE3889259D1 (de) Trapidil enthaltende pharmazeutische Zusammensetzungen und Verfahren zu ihrer Herstellung.
ATE64307T1 (de) Injizierbare arzneiformulierungen von substanzen mit allgemeiner anaesthetischer wirkung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties